Fast vs. slow: which oral allergy treatment works best for kids?

NCT ID NCT06976775

Recruiting now Disease control Sponsor: Pablo Rodríguez del Rio Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two ways of giving oral immunotherapy to children aged 6–16 with milk or egg allergy. One method uses daily increasing doses over a week ('rush'), while the other uses doses every two weeks ('conventional'). The goal is to see which is safer and more effective at helping children tolerate these foods, and to find biological markers that predict success.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: oral immunotherapy (milk or egg protein)
What this could lead to: If successful, this could identify a safer, more efficient way to desensitize children to milk or egg, reducing allergic reactions from accidental exposure.
What could go wrong: This is a small, early-phase trial (Phase 2/3) with only 40 children. The faster 'rush' regimen may cause more side effects, and results may not apply to all allergic children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COW'S MILK ALLERGY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

allergic disease anaphylaxis Egg Hypersensitivity food allergy Heiner syndrome Milk Hypersensitivity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EGG ALLERGY FOOD ALLERGY IN CHILDREN MILK ALLERGY

Contacts and locations

Locations

Hospital Infantil Universitario Niño Jesús. Avenida de Menéndez Pelayo, número 65
RECRUITING

Madrid, 28009, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.